O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY

✍ Scribed by Wedemeyer, H.; Yurdaydin, C.; Ernst, S.; Caruntu, F.A.; Curescu, M.G.; Yalcin, K.; Akarca, U.S.; Gürel, S.; Zeuzem, S.; Erhardt, A.; Lüth, S.; Papatheodoridis, G.V.; Keskin, O.; Port, K.; Radu, M.; Celen, M.K.; Ildeman, R.; Stift, J.; Heidrich, B.; Mederacke, I.; Hardtke, S.; Koch, A.; Dienes, H.P.; Manns, M.P.

• Book ID: 122167823
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 106 KB
• Volume: 60
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(14)60006-4